TODD STRATEGY GROUP

Lobbying for PFIZER INC. · Biopharmaceutical company.

Filing Registration - Amendment

2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · posted Mar 17, 2026

Lobbying activity 3

Pharmacy

Issues related to FDA regulation of pharmaceuticals. Issues related to tariff and trade policy. International Supply Chain.

Tariff (miscellaneous tariff bills)

Issues related to FDA regulation of pharmaceuticals. Issues related to tariff and trade policy. International Supply Chain.

Trade (domestic/foreign)

Issues related to FDA regulation of pharmaceuticals. Issues related to tariff and trade policy. International Supply Chain.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.